Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK2 | P24941 | 2/20 | 0.32 |
| ▸ | CBLB | Q13191 | 4/20 | 0.31 |
| ▸ | BUB1 | O43683 | 1/20 | 0.31 |
| ▸ | TBK1 | Q9UHD2 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.31 |
| ▸ | GSK3B | P49841 | 1/20 | 0.31 |
| ▸ | IL17A | Q16552 | 3/20 | 0.31 |
| ▸ | MBOAT4 | Q96T53 | 1/20 | 0.30 |
| ▸ | CTSS | P25774 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 2/20 | 0.30 |
| ▸ | RAB9A | P51151 | 2/20 | 0.30 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30953094 | 0.92 | IL17A (0.35) | CBLBTBK1IL17A | |
| SCHEMBL30953075 | 0.92 | IL17A (0.38) | CDK2BUB1TBK1LMNASMN1; SMN2 | |
| SCHEMBL30952924 | 0.91 | MEN1 (0.33) | CDK2LMNASMN1; SMN2CCNE1IL17A | |
| SCHEMBL30953101 | 0.91 | CDK2 (0.33) | CDK2BUB1CCNE1GSK3BIL17A | |
| SCHEMBL30952982 | 0.89 | IL17A (0.40) | CDK2CCNE1GSK3BIL17A | |
| SCHEMBL30953011 | 0.87 | IL17A (0.37) | CDK2BUB1LMNASMN1; SMN2CCNE1 | |
| SCHEMBL30953003 | 0.86 | IL17A (0.36) | CBLBIL17A | |
| SCHEMBL30953084 | 0.85 | IL17A (0.40) | CBLBIL17A | |
| SCHEMBL30952976 | 0.84 | IL17A (0.36) | CDK2BUB1CCNE1GSK3BIL17A | |
| SCHEMBL30953449 | 0.83 | PIK3C3 (0.33) | CBLBTBK1LMNARAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4630115-A1 | THERAPEUTIC COMPOUNDS | Sanofi (FR) | 2025-10-15 | — | — | EP | claimed |
| WO-2024121427-A1 | THERAPEUTIC COMPOUNDS | SANOFI (FR) | 2024-06-13 | — | — | WO | claimed |
| EP-4630115-A1 | THERAPEUTIC COMPOUNDS | Sanofi (FR) | 2025-10-15 | — | — | EP | disclosed |
| WO-2024121427-A1 | THERAPEUTIC COMPOUNDS | SANOFI (FR) | 2024-06-13 | — | — | WO | disclosed |